Reduced mucosal antimicrobial activity in Crohn's disease of the colon

Nuding, Sabine; Fellermann, Klaus; Wehkamp, Jan; Stange, Eduard F.
September 2007
Gut;Sep2007, Vol. 56 Issue 9, p1240
Academic Journal
Objectives: In order to maintain the mucosal barrier against luminal microorganisms the intestinal epithelial cells synthesise various broad-spectrum antimicrobial peptides including defensins and cathelicidins. Recent studies indicate that both may be deficient in Crohn's disease. To elucidate the possible functional consequences of this deficiency antimicrobial activity in colonic mucosa from patients with inflammatory bowel disease and healthy controls was investigated. Methods: A flow cytometric assay was established to quantitate bacterial killing and test the antibacterial activity of cationic peptide extracts from colonic biopsies taken from patients with active or inactive ileocolonic or colonic Crohn's disease (n = 22), ulcerative colitis (n = 29) and controls (n = 13) against clinical isolates of Bacteroides vulgatus and Enterococcus faecalis or the reference strains Escherichia coil American Type Culture Collection (ATCC) 25922 and Staphylococcus aureus ATCC 25923. Results: Compared with controls and ulcerative colitis there was a reduced antimicrobial effect in Crohn's disease extracts that was most evident against B. vulgatus. The antimicrobial effect against E. coil and E. faecalis was significantly lower in Crohn's disease compared with ulcerative colitis. Activity against S. aureus disclosed a similar pattern, but was less pronounced. The differences were independent of the inflammation status or concurrent steroid treatment. Bacteria incubated with biopsy extracts from ulcerative colitis patients frequently showed a characteristic change in cell size and granularity, compatible with more extensive membrane disintegration, compared with bacteria incubated with extracts from controls or Crohn's disease. Conclusion: Crohn's disease of the colon is characterized by a diminished functional antimicrobial activity that is consistent with the reported low antibacterial peptide expression.


Related Articles

  • Editorial: Bugs and Drugs: Insights into the Pathogenesis of Inflammatory Bowel Disease. Nguyen, Geoffrey C // American Journal of Gastroenterology;Dec2011, Vol. 106 Issue 12, p2143 

    The dysbiosis hypothesis posits that perturbations in the gut microbiome may contribute to the development of inflammatory bowel disease (IBD). A recent Canadian population-based study has shown an association between new-onset IBD and antibiotic use in the 2-5 years preceding diagnosis. Though...

  • Guía para la interpretación de biopsias endoscópicas con sospecha de enfermedad inflamatoria intestinal idiopática. Colina, Francisco; Ibarrola, Carolina; Salamanca, Javier; López Alonso, Guadalupe; Rodríguez Gil, Yolanda // Revista Española de Patología;jul-sep2014, Vol. 47 Issue 3, p161 

    The lately increasing cases of inflammatory bowel disease (IBD) in the European population have triggered the creation of specific multidisciplinary units in hospitals, and protocols and consensus of specific action that keep pathologist struggling with. Consequently, the increasing demand of...

  • Innate immunity includes defensins. Jägra, Simon; Wehkampb, Jan; Stangea, Eduard F. // Annals of Gastroenterology;Jan2012, Vol. 25, p3 

    The authors comment on a study by T. Karantanos et al on genetics and innate immunity in inflammatory bowel disease (IBD). They agree with the authors' appreciation of the important role of innate immune sensing and the production of antimicrobial peptides in maintaining the integrity of the...

  • Inflammatory bowel disease: an impaired barrier disease. Jäger, Simon; Stange, Eduard; Wehkamp, Jan // Langenbeck's Archives of Surgery;Jan2013, Vol. 398 Issue 1, p1 

    Background: The intestinal barrier is a delicate structure composed of a single layer of epithelial cells, the mucus, commensal bacteria, immune cells, and antibodies. Furthermore, a wealth of antimicrobial peptides (AMPs) can be found in the mucus and defend the mucosa. Different lines of...

  • Erythema ab igne and Crohn's disease. Tighe, M. P.; Morenas, R. A.; Afzal, N. A.; Beaftie, R. M. // Archives of Disease in Childhood;May2008, Vol. 93 Issue 5, p389 

    The article discusses the case of a 13-year-old boy diagnosed with the cases of Crohn's disease and erythema ab igne. The boy is seen with a two-month history of abdominal pain, bloody diarrhea, and weight loss which, when examined through endoscopy and biopsy, confirms Crohn's disease. The skin...

  • Biologies can treat some cases of inflammatory bowel disease. Zablocki, Elaine // Managed Healthcare Executive;Dec2009, Vol. 19 Issue 12, p25 

    The article discusses the inflammatory bowel disease (IBD) in the U.S. in which the intestines become inflamed as a result of immune reaction mobilized against intestinal tissue. It notes that ulcerative colitis affects the rectum and colon while Crohn's disease affects the gastrointestinal...

  • Failure of Synbiotic 2000 to Prevent Postoperative Recurrence of Crohn’s Disease. Irit Chermesh; Ada Tamir; Ron Reshef; Yehuda Chowers; Alain Suissa; Dalia Katz; Moshe Gelber; Zamir Halpern; Stig Bengmark; Rami Eliakim // Digestive Diseases & Sciences;Feb2007, Vol. 52 Issue 2, p385 

    Abstract??Complications of Crohn?s disease (CD) lead to surgery in about 70?90% of patients. The majority of patients suffer from relapse of the disease. Colonic bacteria are essential to the development of CD. Therefore, a rationale exists in trying to prevent relapse by manipulation of gut...

  • Association Between the Use of Antibiotics and New Diagnoses of Crohn's Disease and Ulcerative Colitis. Shaw, Souradet Y; Blanchard, James F; Bernstein, Charles N // American Journal of Gastroenterology;Dec2011, Vol. 106 Issue 12, p2133 

    OBJECTIVES:The objective of this study was to determine if the use of antibiotics 2-5 years before diagnosis was associated with the development of inflammatory bowel disease (IBD).METHODS:This was a nested case-control analysis of the population-based University of Manitoba Inflammatory Bowel...

  • Direct Bacterial Killing In Vitro by Recombinant Nod2 Is Compromised by Crohn's Disease-Associated Mutations. Perez, Laurent-Herve; Butler, Matt; Creasey, Tammy; Dzink-Fox, JoAnn; Gounarides, John; Petit, Stephanie; Ropenga, Anna; Ryder, Neil; Smith, Kathryn; Smith, Philip; Parkinson, Scott J. // PLoS ONE;2010, Vol. 5 Issue 6, p1 

    Background: A homeostatic relationship with the intestinal microflora is increasingly appreciated as essential for human health and wellbeing. Mutations in the leucine-rich repeat (LRR) domain of Nod2, a bacterial recognition protein, are associated with development of the inflammatory bowel...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics